FDA Investigator: Anissa M. Cheung

- Anissa M. Cheung first started conducting FDA inspections in 2016, with the last inspection in 2024. Over that time, Anissa M. Cheung has conducted 17 inspections at 12 companies across 15 sites.

Get Anissa Cheung's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Serum Institute of India Pvt. Ltd., Pune | 2024

Out-of-stock
Anissa M. Cheung
Biologics Form 483

FDA 483 MedImmune U.K. Limited, Liverpool | 2024

Out-of-stock
Anissa M. Cheung
Biologics Form 483

FDA 483 Valneva Scotland Ltd., Livingston | 2024

Out-of-stock
Anissa M. Cheung
Biologics Form 483

FDA 483 Unigen Inc., Ibi-Gun | 2023

Out-of-stock
Anissa M. Cheung
Biologics Form 483

FDA 483 Unigen Inc., Ibi-Gun | 2023

Out-of-stock
Anissa M. Cheung
Biologics Form 483

FDA 483 Valneva Scotland Ltd., Livingston | 2022

Out-of-stock
Anissa M. Cheung
Biologic Form 483

FDA 483 Serum Institute of India Pvt. Ltd., Manjari | 2022

Out-of-stock
Anissa M. Cheung
Biologic Form 483

FDA 483 Merck Sharp & Dohme Corp., West Point | 2019

Out-of-stock
Anissa M. Cheung
Biologic Form 483

FDA 483 Bavarian Nordic A/S, Kvistgard | 2019

Out-of-stock
Anissa M. Cheung
Biologic Form 483

FDA 483 Seqirus Pty Ltd, Parkville | 2018

Out-of-stock
Anissa M. Cheung
Biologic Form 483

FDA 483 Sanofi Pasteur SA, Marcy L Etoile | 2017

Out-of-stock
Anissa M. Cheung
Biologic Form 483